Miniature multi-channel SPR instrument for methotrexate monitoring in clinical samples

Biosensors and Bioelectronics

Volumn 64, Issue , 2015, Pages 664-670

  Zhao, Sandy Shuo ^a   Bukar, Natalia ^a   Toulouse, Jacynthe L ^a,c   Pelechacz, Daniel ^a   Robitaille, Robert ^b   Pelletier, Joelle N ^a,c   Masson, Jean François ^a,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Centre de Recherche   (Canada)

^c PROTEO ^*  (Canada)

^d CP 6128 Succursale Centre ville   (Canada)

Author keywords

Biosensors; Gold nanoparticles; Localized surface plasmon resonance; Methotrexate; Surface plasmon resonance; Therapeutic drug monitoring

Indexed keywords

SURFACE PLASMON RESONANCE;

CLINICAL SAMPLES; GOLD NANOPARTICLES; LOCALIZED SURFACE PLASMON RESONANCE; METHOTREXATE; THERAPEUTIC DRUG MONITORING;

BIOSENSORS;

DIHYDROFOLATE REDUCTASE; FOLIC ACID; GOLD NANOPARTICLE; METHOTREXATE; PHOSPHATE; ANTINEOPLASTIC ANTIMETABOLITE; DRUG MIXTURE;

ARTICLE; BINDING AFFINITY; BIOCHEMICAL EQUIPMENT; BIOSENSOR; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MONITORING; DRUG RECEPTOR BINDING; EQUIPMENT DESIGN; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MINIATURE MULTI CHANNEL SURFACE PLASMON RESONANCE SYSTEM; PARTICLE SIZE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SURFACE PLASMON RESONANCE; VALIDATION PROCESS; ANALYSIS; BLOOD; CHEMISTRY; DEVICE FAILURE ANALYSIS; DEVICES; DRUG MIXTURE; ELECTRONICS; ILLUMINATION;

ANTIMETABOLITES, ANTINEOPLASTIC; COMPLEX MIXTURES; DRUG MONITORING; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; LIGHTING; METHOTREXATE; MINIATURIZATION; SURFACE PLASMON RESONANCE;

EID: 84908318612     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2014.09.082     Document Type: Article

References (31)

1. Abbas A., Linman M.J., Cheng Q. Biosens. Bioelectron. 2011, 26(5):1815-1824.
2. AbbottLaboratories TDX/TDXFLX-Methotrexate II-Technical Manual 2009, Abbott Laboratories Diagnostic division, Abbott Park, IL.
3. Ackland S.P., Schilsky R.L. J. Clin. Oncol. 1987, 5(12):2017-2031.
4. Albertioni F., Rask C., Eksborg S., Poulsen J.H., Pettersson B., Beck O., Schroeder H., Peterson C. Clin. Chem. 1996, 42(1):39-44.
5. ArkDiagnostics, 2013. http://www.ark-tdm.com/pdfs/AACC2011Methotrexate_11x17.pdf, (accessed 02.10.13).
6. Aumente D., Buelga D.S., Lukas J.C., Gomez P., Torres A., Garcia M.J. Clin. Pharmacokinet. 2006, 45(12):1227-1238.
7. Bhattacharyya S., Kudgus R.A., Bhattacharya R., Mukherjee P. Pharm. Res. 2011, 28(2):237-259.
8. Biosuplar, 2012. (accessed 16.12.12). http://www.biosuplar.de/.
9. Blum R., Seymour J.F., Toner G. Ann. Oncol. 2002, 13(2):327-330.
10. Bolduc O.R., Lambert-Lanteigne P., Colin D.Y., Zhao S.S., Proulx C., Boeglin D., Lubell W.D., Pelletier J.N., Fethiere J., Ong H., Masson J.-F. Analyst 2011, 136(15):3142-3148.
11. Breault-Turcot J., Masson J.-F. Anal. Bioanal. Chem. 2012, 403(6):1477-1484.
12. Bukar N., Zhao S.S., Charbonneau D.M., Pelletier J.N., Masson J.-F. Chem. Commun. 2014, 50(38):4947-4950.
13. Chen Y.H., Tsai C.Y., Huang P.Y., Chang M.Y., Cheng P.C., Chou C.H., Chen D.H., Wang C.R., Shiau A.L., Wu C.L. Mol. Pharm. 2007, 4(5):713-722.
14. Chinowsky T.M., Soelberg S.D., Baker P., Swanson N.R., Kauffman P., Mactutis A., Grow M.S., Atmar R., Yee S.S., Furlong C.E. Biosens. Bioelectron. 2007, 22(9-10):2268-2275.
15. Dasgupta A. Handbook of Drug Monitoring Methods 2008, Humana Press Inc., Totowa, NJ.
16. Fossati E., Volpato J.P., Poulin L., Guerrero V., Dugas D.A., Pelletier J.N. J. Biomol. Screen. 2008, 13(6):504-514.
17. Graf N., Winkler K., Betlemovic M., Fuchs N., Bode U. J. Clin. Oncol. 1994, 12(7):1443-1451.
18. Homola J. Anal. Bioanal. Chem. 2003, 377(3):528-539.
19. KMAC, 2012. (accessed 16.12.12). http://www.kmac.to/eng/product/php?cid=sprlab.
20. Marchesini G.R., Koopal K., Meulenberg E., Haasnoot W., Irth H. Biosens. Bioelectron. 2007, 22(9-10):1908-1915.
21. Mendu D.R., Chou P.P., Soldin S.J. Ther. Drug Monit. 2007, 29(5):632-637.
22. Naimushin A.N., Soelberg S.D., Nguyen D.K., Dunlap L., Bartholomew D., Elkind J., Melendez J., Furlong C.E. Biosens. Bioelectron. 2002, 17(6-7):573-584.
23. NTT-AT, 2012. (accessed 16.12.12). http://www.ntt-at.com/products_e/handy_spr/.
24. Pignon T., Lacarelle B., Duffaud F., Guillet P., Catalin J., Durand A., Monjanel S., Favre R. Cancer Chemother. Pharmacol. 1994, 33(5):420-424.
25. Ratel M., Provencher-Girard A., Zhao S.S., Breault-Turcot J., Labrecque-Carbonneau J., Branca M., Pelletier J.N., Schmitzer A.R., Masson J.F. Anal. Chem. 2013, 85(12):5770-5777.
26. Springer T., Piliarik M., Homola J. Anal. Bioanal. Chem. 2010, 398(5):1955-1961.
27. Steinborner S., Henion J. Anal. Chem. 1999, 71(13):2340-2345.
28. Volpato J.P., Yachnin B.J., Blanchet J., Guerrero V., Poulin L., Fossati E., Berghuis A.M., Pelletier J.N. J. Biol. Chem. 2009, 284(30):20079-20089.
29. Volpato J.P., Mayotte N., Fossati E., Guerrero V., Sauvageau G., Pelletier J.N. J. Mol. Recognit. 2011, 24(2):188-198.
30. Walling J. Invest. New Drugs 2006, 24(1):37-77.
31. Zhao S.S., Bichelberger M.A., Colin D.Y., Robitaille R., Pelletier J.N., Masson J.F. Analyst 2012, 137(20):4742-4750.